Cue Biopharma, Inc. (CUE)
 NASDAQ: CUE · Real-Time Price · USD
 0.6994
 +0.0094 (1.36%)
  Oct 30, 2025, 4:00 PM EDT - Market closed
Cue Biopharma Market Cap
Cue Biopharma has a market cap or net worth of $53.75 million as of October 31, 2025. Its market cap has decreased by -26.23% in one year.
Market Cap 
 53.75M
Enterprise Value 
 33.42M
1-Year Change 
 -26.23%
Ranking 
 Category 
 Stock Price 
$0.70
Market Cap Chart
Since January 2, 2018, Cue Biopharma's market cap has decreased from $226.28M to $53.75M, a decrease of -76.25%. That is a compound annual growth rate of -16.78%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 29, 2025 | 53.02M | -23.21% | 
| Dec 31, 2024 | 69.05M | -42.03% | 
| Dec 29, 2023 | 119.13M | -2.89% | 
| Dec 30, 2022 | 122.67M | -65.85% | 
| Dec 31, 2021 | 359.22M | -5.17% | 
| Dec 31, 2020 | 378.78M | 3.77% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | 
| Jan 2, 2018 | Upgrade Pro | Upgrade Pro | 
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Eli Lilly and Company | 730.33B | 
| Johnson & Johnson | 449.57B | 
| AbbVie | 397.72B | 
| UnitedHealth Group | 321.75B | 
| AstraZeneca | 257.84B | 
| Novartis AG | 237.42B | 
| Novo Nordisk | 232.34B | 
| Abbott Laboratories | 216.57B |